AAAAAA
Results: 1-25/33
Authors:
BRIELMEIER M
BECHET JM
FALK MH
PAWLITA M
POLACK A
BORNKAMM GW
Citation: M. Brielmeier et al., IMPROVING STABLE TRANSFECTION EFFICIENCY - ANTIOXIDANTS DRAMATICALLY IMPROVE THE OUTGROWTH OF CLONES UNDER DOMINANT MARKER SELECTION, Nucleic acids research, 26(9), 1998, pp. 2082-2085
Authors:
MESCHEDE W
ZUMBACH K
BRASPENNING J
SCHEFFNER M
BENITEZBRIBIESCA L
LUANDE J
GISSMANN L
PAWLITA M
Citation: W. Meschede et al., ANTIBODIES AGAINST EARLY PROTEINS OF HUMAN PAPILLOMAVIRUSES AS DIAGNOSTIC MARKERS FOR INVASIVE CERVICAL-CANCER, Journal of clinical microbiology, 36(2), 1998, pp. 475-480
Authors:
JOX A
TAQUIA E
VOCKERODT M
DRAUBE A
PAWLITA M
MOLLER P
BULLERDIEK J
DIEHL V
WOLF J
Citation: A. Jox et al., STABLE NONTUMORIGENIC PHENOTYPE OF SOMATIC-CELL HYBRIDS BETWEEN MALIGNANT BURKITTS-LYMPHOMA CELLS AND AUTOLOGOUS EBV-IMMORTALIZED B-CELLS DESPITE INDUCTION OF CHROMOSOMAL BREAKAGE AND LOSS, Cancer research, 58(21), 1998, pp. 4930-4939
Authors:
BARTH TFE
DOHNER H
WERNER CA
STILGENBAUER S
SCHLOTTER M
PAWLITA M
LICHTER P
MOLLER P
BENTZ M
Citation: Tfe. Barth et al., CHARACTERISTIC PATTERN OF CHROMOSOMAL GAINS AND LOSSES IN PRIMARY LARGE B-CELL LYMPHOMAS OF THE GASTROINTESTINAL-TRACT, Blood, 91(11), 1998, pp. 4321-4330
Authors:
MUCKE S
POLACK A
PAWLITA M
ZEHNPFENNIG D
MASSOUDI N
BOHLEN H
DOERFLER W
BORNKAMM G
DIEHL V
WOLF J
Citation: S. Mucke et al., SUITABILITY OF EPSTEIN-BARR VIRUS-BASED EPISOMAL VECTORS FOR EXPRESSION OF CYTOKINE GENES IN HUMAN LYMPHOMA-CELLS, Gene therapy, 4(2), 1997, pp. 82-92
Authors:
LANGNER J
PAWLITA M
Citation: J. Langner et M. Pawlita, VIRAL PARTICLES WITH HETEROLOGOUS BINDING MOTIFS - AN APPROACH TO SPECIFICALLY ALTER THE TROPISM OF THE B-LYMPHOTROPIC PAPOVAVIRUS, Cancer gene therapy, 4(5), 1997, pp. 325-325
Authors:
JOX A
ROHEN C
BELGE G
BARTNITZKE S
PAWLITA M
DIEHL V
BULLERDIEK J
WOLF J
Citation: A. Jox et al., INTEGRATION OF EPSTEIN-BARR-VIRUS IN BURKITTS-LYMPHOMA CELLS LEADS TOA REGION OF ENHANCED CHROMOSOME INSTABILITY, Annals of oncology, 8, 1997, pp. 131-135
Authors:
HERRMANN M
VONDERLIETH CW
STEHLING P
REUTTER W
PAWLITA M
Citation: M. Herrmann et al., CONSEQUENCES OF A SUBTLE SIALIC-ACID MODIFICATION ON THE MURINE POLYOMAVIRUS RECEPTOR, Journal of virology, 71(8), 1997, pp. 5922-5931
Authors:
BARTH TFE
DOHNER H
STILGENBAUER S
WERNER CA
SCHLOTTER M
PAWLITA M
LICHTER P
MOLLER P
BENTZ M
Citation: Tfe. Barth et al., CHARACTERISTIC PATTERNS OF CHROMOSOMAL-ABERRATIONS IN PRIMARY LARGE B-CELL LYMPHOMAS OF THE GASTROINTESTINAL-TRACT, Blood, 90(10), 1997, pp. 3871-3871
Authors:
WILLHAUCK M
MOHLER T
SCHEIBENBOGEN C
PAWLITA M
BROSSART P
SCHMIER JW
KEILHOLZ U
Citation: M. Willhauck et al., T-CELL RECEPTOR-BETA VARIABLE REGION DIVERSITY IN MELANOMA METASTASESAFTER INTERLEUKIN 2-BASED IMMUNOTHERAPY, Clinical cancer research, 2(4), 1996, pp. 767-772
Authors:
JOCHNER N
EICK D
ZIMBERSTROBL U
PAWLITA M
BORNKAMM GW
KEMPKES B
Citation: N. Jochner et al., EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 IS A TRANSCRIPTIONAL SUPPRESSOR OF THE IMMUNOGLOBULIN MU GENE - IMPLICATIONS FOR THE EXPRESSION OF THETRANSLOCATED C-MYC GENE IN BURKITTS-LYMPHOMA CELLS, EMBO journal, 15(2), 1996, pp. 375-382
Authors:
PAWLITA M
MULLER M
OPPENLANDER M
ZENTGRAF H
HERRMANN M
Citation: M. Pawlita et al., DNA ENCAPSIDATION BY VIRUS-LIKE PARTICLES ASSEMBLED IN INSECT CELLS FROM THE MAJOR CAPSID PROTEIN VP1 OF B-LYMPHOTROPIC PAPOVAVIRUS, Journal of virology, 70(11), 1996, pp. 7517-7526
Authors:
KEMPKES B
ZIMBERSTROBL U
EISSNER G
PAWLITA M
FALK M
HAMMERSCHMIDT W
BORNKAMM GW
Citation: B. Kempkes et al., EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2)-ESTROGEN RECEPTOR FUSIONPROTEINS COMPLEMENT THE EBNA2-DEFICIENT EPSTEIN-BARR-VIRUS STRAIN P3HR1 IN TRANSFORMATION OF PRIMARY B-CELLS BUT SUPPRESS GROWTH OF HUMAN B-CELL LYMPHOMA LINES, Journal of General Virology, 77, 1996, pp. 227-237
Authors:
MUCKE S
POLACK A
PAWLITA M
MOLLER P
BORNKAMM G
DOERFLER W
DIEHL V
WOLF J
Citation: S. Mucke et al., TUMORSUPPRESSION AFTER CYTOKINE GENE-TRANSFER INTO BURKITT-LYMPHOMA CELLS IN A MOUSE MODEL, Blood, 88(10), 1996, pp. 3925-3925
Authors:
MOHLER T
WILLHAUCK M
SCHEIBENBOGEN C
PAWLITA M
BLUDAU H
BROSSART P
HUNSTEIN W
KEILHOLZ U
Citation: T. Mohler et al., RESTRICTION OF T-CELL RECEPTOR V-BETA REPERTOIRE IN MELANOMA METASTASIS RESPONDING TO IMMUNOTHERAPY, Melanoma research, 5(2), 1995, pp. 129-132
Authors:
KISCHKEL FC
HELLBARDT S
BEHRMANN I
GERMER M
PAWLITA M
KRAMMER PH
PETER ME
Citation: Fc. Kischkel et al., CYTOTOXICITY-DEPENDENT APO-1 (FAS CD95)-ASSOCIATED PROTEINS FORM A DEATH-INDUCING SIGNALING COMPLEX (DISC) WITH THE RECEPTOR/, EMBO journal, 14(22), 1995, pp. 5579-5588
Authors:
KEMPKES B
PAWLITA M
ZIMBERSTROBL U
EISSNER G
LAUX G
BORNKAMM GW
Citation: B. Kempkes et al., EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 ESTROGEN-RECEPTOR FUSION PROTEINS TRANSACTIVATE VIRAL AND CELLULAR GENES AND INTERACT WITH RBP-J-KAPPAIN A CONDITIONAL FASHION, Virology, 214(2), 1995, pp. 675-679
Authors:
WOLF J
JOX A
SKARBEK H
PUKROP T
BARTNITZKE S
PAWLITA M
DIEHL V
BULLERDIEK J
Citation: J. Wolf et al., SELECTIVE LOSS OF INTEGRATED EPSTEIN-BARR-VIRUS GENOMES AFTER LONG-TERM CULTIVATION OF BURKITTS-LYMPHOMA X B-LYMPHOBLASTOID CELL HYBRIDS DUE TO CHROMATIN INSTABILITY AT THE INTEGRATION SITE, Virology, 212(1), 1995, pp. 179-185
Authors:
HERRMANN M
OPPENLANDER M
PAWLITA M
Citation: M. Herrmann et al., FAST AND HIGH-AFFINITY BINDING OF B-LYMPHOTROPIC PAPOVAVIRUS TO HUMANB-LYMPHOMA CELL-LINES, Journal of virology, 69(11), 1995, pp. 6797-6804
Authors:
TERMEULEN J
YU X
MGAYA HN
CHANGCLAUDE J
NAHER H
MEINHARD G
MKIWA M
PAWLITA M
Citation: J. Termeulen et al., PREVALENCE OF TRANSFORMATION ZONE CHLAMYDIA-TRACHOMATIS DNA AND SERUMANTIBODIES IN TANZANIAN GYNECOLOGICAL INPATIENTS, Journal of tropical medicine and hygiene, 98(2), 1995, pp. 89-94
Authors:
KEPPLER OT
STEHLING P
HERRMANN M
KAYSER H
GRUNOW D
REUTTER W
PAWLITA M
Citation: Ot. Keppler et al., BIOSYNTHETIC MODULATION OF SIALIC ACID-DEPENDENT VIRUS-RECEPTOR INTERACTIONS OF 2 PRIMATE POLYOMA VIRUSES, The Journal of biological chemistry, 270(3), 1995, pp. 1308-1314
Authors:
WOLF J
DRAUBE A
BOHLEN H
JOX A
MUCKE S
PAWLITA M
MOLLER P
DIEHL V
Citation: J. Wolf et al., SUPPRESSION OF BURKITTS-LYMPHOMA TUMORIGENICITY IN NUDE-MICE BY CO-INOCULATION OF EBV-IMMORTALIZED LYMPHOBLASTOID-CELLS, International journal of cancer, 60(4), 1995, pp. 527-533
Authors:
LARCHER C
KEMPKES B
KREMMER E
PRODINGER WM
PAWLITA M
BORNKAMM GW
DIERICH MP
Citation: C. Larcher et al., EXPRESSION OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2) INDUCES CD21 CR2 ON B-CELL AND T-CELL LINES AND SHEDDING OF SOLUBLE CD21/, European Journal of Immunology, 25(6), 1995, pp. 1713-1719
Authors:
JOX A
SKARBEK H
PUKROP T
BARTNITZKE S
PAWLITA M
DIEHL V
BULLERDIEK J
WOLF J
Citation: A. Jox et al., LOSS OF INTEGRATED EPSTEIN-BARR-VIRUS IN BURKITTS-LYMPHOMA CELL HYBRIDS DUE TO CHROMATIN INSTABILITY AT THE INTEGRATION SITE, Blood, 86(10), 1995, pp. 3249-3249
Authors:
MUCKE S
POLACK A
PAWLITA M
BORNKAMM G
DOERFLER W
DIEHL V
WOLF J
Citation: S. Mucke et al., CYTOKINE TRANSFER INTO HUMAN NON-HODGKIN-LYMPHOMA CELLS, Blood, 86(10), 1995, pp. 4000-4000